← FDA Drug Approvals (Drugs@FDA)

DOCOSANOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2024-03-01

Drug application

FDA Application #
ANDA217090
Application type
Abbreviated New Drug Application (Generic)
Brand name
DOCOSANOL
Generic name
DOCOSANOL
Active ingredients
DOCOSANOL
Dosage form
CREAM
Route
TOPICAL
Marketing status
Over-the-counter
Sponsor
AUROBINDO PHARMA LTD
Manufacturer
Amazon.com Services LLC
First approval
2024-03-01

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown